☰

Robert Karoly, Ph.D. - Publications

Affiliations: 
2010 Semmelweis Egyetem, Hungary 
Area:
Neuroscience Biology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

10/19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Lenkey N, Karoly R, Epresi N, Vizi ES, Mike A. Binding of sodium channel inhibitors to hyperpolarized and depolarized conformations of the channel Neuropharmacology. 60: 191-200. PMID 20713065 DOI: 10.1016/j.neuropharm.2010.08.005  0.795
2010 Lenkey N, Karoly R, Lukacs P, Vizi ES, Sunesen M, Fodor L, Mike A. Classification of drugs based on properties of sodium channel inhibition: a comparative automated patch-clamp study. Plos One. 5: e15568. PMID 21187965 DOI: 10.1371/journal.pone.0015568  0.79
2010 Karoly R, Lenkey N, Juhasz AO, Vizi ES, Mike A. Fast- or slow-inactivated state preference of Na+ channel inhibitors: a simulation and experimental study. Plos Computational Biology. 6: e1000818. PMID 20585544 DOI: 10.1371/journal.pcbi.1000818  0.795
2010 Lenkey N, Karoly R, Lukacs P, Vizi ES, Sunesen M, Fodor L, Mike A. A Comparative Automated Electrophysiology Study of 43 Sodium Channel Inhibitors. Distinct Types of Inhibition Correlate with Chemical Properties of Drugs Biophysical Journal. 98: 113a. DOI: 10.1016/j.bpj.2009.12.4206  0.799
2007 Mike A, Lenkey N, Karoly R, Vizi ES. Exploring the heterogeneity of use-dependent sodium channel inhibitor drugs. II: Drugs described by the modulated receptor hypothesis (MRH) and/or the guarded receptor hypothesis (GRH) Bmc Pharmacology. 7. DOI: 10.1186/1471-2210-7-S2-A42  0.761
2007 Lenkey N, Karoly R, Vizi ES, Mike A. Exploring the heterogeneity of use-dependent sodium channel inhibitor drugs. I: Fast- vs. slow-inactivated state preference Bmc Pharmacology. 7: A41. DOI: 10.1186/1471-2210-7-S2-A41  0.806
2006 Lenkey N, Karoly R, Kiss JP, Szasz BK, Vizi ES, Mike A. The mechanism of activity-dependent sodium channel inhibition by the antidepressants fluoxetine and desipramine. Molecular Pharmacology. 70: 2052-63. PMID 16985186 DOI: 10.1124/mol.106.026419  0.799
2006 Karoly R, Lenkey N, Mike A, Vizi ES. Modelling drug effects on sodium channels Autonomic and Autacoid Pharmacology. 26: 91.  0.789
2004 Mike A, Karoly R, Vizi ES, Kiss JP. A novel modulatory mechanism of sodium currents: frequency-dependence without state-dependent binding. Neuroscience. 125: 1019-28. PMID 15120861 DOI: 10.1016/j.neuroscience.2004.02.036  0.4
2003 Mike A, Karoly R, Vizi ES, Kiss JP. Inhibitory effect of the DA uptake blocker GBR 12909 on sodium channels of hippocampal neurons. Neuroreport. 14: 1945-9. PMID 14561926 DOI: 10.1097/01.wnr.0000091412.19795.2e  0.371
Low-probability matches (unlikely to be authored by this person)
2007 Szasz BK, Mike A, Karoly R, Gerevich Z, Illes P, Vizi ES, Kiss JP. Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system. Biological Psychiatry. 62: 1303-9. PMID 17659262 DOI: 10.1016/j.biopsych.2007.04.014  0.228
2010 McCormack TJ, Melis C, Colón J, Gay EA, Mike A, Karoly R, Lamb PW, Molteni C, Yakel JL. Rapid desensitization of the rat α7 nAChR is facilitated by the presence of a proline residue in the outer β-sheet. The Journal of Physiology. 588: 4415-29. PMID 20837638 DOI: 10.1113/Jphysiol.2010.195495  0.222
2008 Karoly R, Mike A, Illes P, Gerevich Z. The unusual state-dependent affinity of P2X3 receptors can be explained by an allosteric two-open-state model Molecular Pharmacology. 73: 224-234. PMID 17925459 DOI: 10.1124/mol.107.038901  0.191
2010 Vizi ES, Fekete A, Karoly R, Mike A. Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment. British Journal of Pharmacology. 160: 785-809. PMID 20136842 DOI: 10.1111/j.1476-5381.2009.00624.x  0.151
2009 Karoly R. Molecular targeted therapy for endocrine tumors Orvoskepzes. 84: 239-244.  0.101
2007 Karoly R, Mike A, Gerevich Z, Illes P, Vizi ES. Evidence against a separate high affinity binding site on the P2X3 receptor Bmc Pharmacology. 7. DOI: 10.1186/1471-2210-7-S2-A38  0.083
2005 Jobbágy A, Harcos P, Karoly R, Fazekas G. Analysis of finger-tapping movement. Journal of Neuroscience Methods. 141: 29-39. PMID 15585286 DOI: 10.1016/j.jneumeth.2004.05.009  0.05
1995 McGorry PD, Mihalopoulos C, Henry L, Dakis J, Jackson HJ, Flaum M, Harrigan S, McKenzie D, Kulkarni J, Karoly R. Spurious precision: procedural validity of diagnostic assessment in psychotic disorders. The American Journal of Psychiatry. 152: 220-3. PMID 7840355 DOI: 10.1176/ajp.152.2.220  0.035
1996 Furukawa T, McGorry PD, Opoulos CM, Henry L, Dakis J, Jackson HJ, Harrigan S, McKenzie D, Kulkarni T, Karoly R. Alternative diagnostic procedures [16] American Journal of Psychiatry. 153: 449-450. PMID 8610853  0.02
Hide low-probability matches.